Injectable Drug Delivery Market Analysis, Top Companies, New Technology, Demand and Opportunity Analysis
The global injectable drug delivery market is growing significantly
due to increasing prevalence of cancer and diabetes, technological advancements
in injectable drug delivery devices, and increased patient adherence to
injectable drug delivery systems in the industry. Massive unexplored injectable
drug delivery market in emerging economies and development of biosimilars and
biologics are creating ample opportunities for the global injectable drug
delivery market to grow at a considerable rate in the coming years. The
advanced research and development facilities and new product developments by
the companies are propelling the demand for cost effective and efficient
injectable drug delivery devices and formulations.
Significant shift from conventional injectable drug delivery devices
to self-injection drug delivery devices is a trend in global injectable drug
delivery market. Increasing prevalence of diabetes has fuelled the demand of
self-injection drug delivery devices; hence, reducing frequent hospital visits
and costs related to it. According to the International Diabetes Federation
(IDF), in 2013, there were 381.8 million people living with diabetes across the
globe and the number was expected to grow to 591.9 million by 2035.
Request to Get the
Sample Pages at: https://www.psmarketresearch.com/market-analysis/injectable-drug-delivery-market/report-sample
The global injectable drug delivery market is categorized as
therapeutic applications, end-users, and products type. Based on therapeutic
applications, the injectable drug delivery market is segmented as oncology
disorders, autoimmune diseases, orphan diseases, hormonal disorders, and
others. The hormonal disorders segment leads the global injectable drug
delivery market due to high prevalence of diabetes. Based on end-users, the
injectable drug delivery market is categorized as hospitals and nursing homes,
research institutes, pharmaceutical and biotechnology companies, and others.
Make Enquiry Before
Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=injectable-drug-delivery-market
Some of the factors driving the growth of the global injectable drug
delivery market are technological advancements in injectable drug delivery
devices, increasing number of diabetes and cancer cases, increasing demand for
self-injection devices, increased patient adherence to injectable drug delivery
systems, and increasing healthcare expenditure. However, stringent regulatory
requirements, patient safety issues such as infection and injuries, development
of substitute drug delivery methods, such as needle-free transmucosal drug
delivery sytems, are some of the factors restraining the growth of the global
injectable drug delivery market.
Some of the major players operating in the global injectable drug delivery market are Becton,
Dickinson and Company, Baxter International, Inc., Novo Nordisk A/S, Terumo
Medical Corp., Sanofi, Schott AG, Ypsomed Holding AG, Antares Pharma, Inc.,
Owen Mumford Ltd., Eli Lilly And Company, and Zogenix, Inc. among others.
Comments
Post a Comment